Latest News and Press Releases
Want to stay updated on the latest news?
-
Pending final negotiation, grant will fund up to 20 patients in the OCTOPOD-IV Phase 2a expansion study of THEO-260 in platinum-resistant ovarian cancerCompetitive funding award highlights Theolytics’...
-
DUBAI, United Arab Emirates, March 04, 2026 (GLOBE NEWSWIRE) -- tpay, the leading payment connector in the Middle East, Turkey, and Africa (META), has won the MEFFYS 2026 Award in the Payment...
-
Daridorexant is a dual orexin receptor antagonist being developed in South Korea by Nxera for the treatment of adult patients with insomnia and is approved and marketed in Japan as QUVIVIQ®Phase 3...
-
JAKARTA, Indonesia, March 04, 2026 (GLOBE NEWSWIRE) -- Otto Media Grup memperkenalkan peningkatan kapabilitas operasional streamer virtual dengan fokus pada jangka panjang, standarisasi, dan...
-
Downing LLPLEI: 213800G3X76VBG9SB50404 March 2026Form 8.3 re. Kitwave Group Plc PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%...
-
Downing LLPLEI: 213800G3X76VBG9SB50404 March 2026Form 8.3 re. Inspecs Group Plc PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%...
-
Downing LLPLEI: 213800G3X76VBG9SB50404 March 2026Form 8.3 re. 1Spatial Plc PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR...
-
Bitget lists Opinion (OPN), a decentralized prediction market and AI oracle platform enabling continuous consensus-based forecasting.
-
Hesai Group to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, March 24, 2026
SHANGHAI, China, March 04, 2026 (GLOBE NEWSWIRE) -- Hesai Group (“Hesai,” “Hesai Technology” or the “Company”) (NASDAQ: HSAI; HKEX: 2525), the global leader in three-dimensional light detection and...
-
— Second clinical candidate from HUTCHMED’s next-generation ATTC platform — — Leveraging synergy through simultaneous inhibition of PAM pathway and EGFR signaling — HONG KONG and SHANGHAI and...